• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Platform technology to generate broadly cross-reactive antibodies to α-helical epitopes in hemagglutinin proteins from influenza a viruses

tetano

Editor, Senior Moderator
Biopolymers. 2016 Jan 21. doi: 10.1002/bip.22808. [Epub ahead of print]
[h=1]Platform technology to generate broadly cross-reactive antibodies to α-helical epitopes in hemagglutinin proteins from influenza a viruses.[/h] Jiang Z[SUP]1[/SUP], Gera L[SUP]1[/SUP], Mant CT[SUP]1[/SUP], Hirsch B[SUP]1,[/SUP][SUP]2[/SUP], Yan Z[SUP]1,[/SUP][SUP]3[/SUP], Qian Z[SUP]4,[/SUP][SUP]5[/SUP], Holmes KV[SUP]5[/SUP], Shortt JA[SUP]1[/SUP], Pollock DD[SUP]1[/SUP], Hodges RS[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] We have utilized a de novo designed two-stranded α-helical coiled-coil template to display conserved α-helical epitopes from the stem region of hemagglutinin (HA) glycoproteins of influenza A. The immunogens have all the surface-exposed residues of the native α-helix in the native HA protein of interest displayed on the surface of the two-stranded α-helical coiled-coil template. This template when used as an immunogen elicits polyclonal antibodies which bind to the α-helix in the native protein. We investigated the highly conserved sequence region 421-476 of HA by inserting 21 or 28 residue sequences from this region into our template. The cross-reactivity of the resulting rabbit polyclonal antibodies prepared to these immunogens was determined using a series of HA proteins from H1N1, H2N2, H3N2, H5N1, H7N7 and H7N9 virus strains which are representative of Group 1 and Group 2 virus subtypes of influenza A. Antibodies from region 449-476 were Group 1 specific. Antibodies to region 421-448 showed the greatest degree of cross-reactivity to Group 1 and Group 2 and suggested that this region has a great potential as a "universal" synthetic peptide vaccine for influenza A. This article is protected by copyright. All rights reserved.
? 2016 Wiley Periodicals, Inc.


[h=4]KEYWORDS:[/h] coiled-coil immunogens; helical epitopes; hemagglutinin; influenza A viruses; synthetic peptide vaccines

PMID: 26799790 [PubMed - as supplied by publisher]
 
Back
Top Bottom